
Tech transfer is key to succession advancing biopharmaceutical pipeline products from research to preclinical.
Barrett Fallentine is director of Product and Process Development, Pharmatech Associates, bfallentine@pai-qbd.com.

Tech transfer is key to succession advancing biopharmaceutical pipeline products from research to preclinical.

Published: February 1st 2019 | Updated: